VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin

Clinical trial NCT00004030 · COMPLETED

Trial details

NCT number: NCT00004030
Sponsor: Georgetown University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1996-03-01
Primary completion: 2001-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.